
doi: 10.1007/bf01310708
pmid: 2155595
Camptothecin (CPT), a specific inhibitor of DNA topoisomerase I, effectively inhibited the replication of herpes simplex virus type 2 (HSV-2). CPT was found to reduce the level of immediate early viral mRNA in a dose-response manner. On the other hand, we could not find any evidence that a novel DNA topoisomerase I was induced in HSV-2-infected cells. Our observations suggest that host cell DNA topoisomerase I is involved in the replication of HSV-2.
DNA Topoisomerases, Type I, Dose-Response Relationship, Drug, Depression, Chemical, Enzyme Induction, Simplexvirus, Camptothecin, Viral Plaque Assay, Topoisomerase I Inhibitors, Virus Replication
DNA Topoisomerases, Type I, Dose-Response Relationship, Drug, Depression, Chemical, Enzyme Induction, Simplexvirus, Camptothecin, Viral Plaque Assay, Topoisomerase I Inhibitors, Virus Replication
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 25 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
